In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
暂无分享,去创建一个
S. Minoshima | J. Fessler | R. Koeppe | N. Foster | D. Kuhl | S. Minoshima | K. Frey | E. Ficaro | D. Wieland | D. E. Kuhl | J. A. Fessler | E. P. Ficaro | D. M. Wieland | R. A. Koeppe | K. A. Frey | N. L. Foster | N. L. Foster
[1] J. Haxby,et al. Positron emission tomography in Alzheimer's disease , 1986, Neurology.
[2] E K Perry,et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. , 1978, British medical journal.
[3] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] T. Bonner,et al. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. , 1994, The Journal of biological chemistry.
[5] E Godaux,et al. Voluntary motor commands in human ballistic movements , 1979, Annals of neurology.
[6] E. Perry,et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. , 1985, Journal of neurology, neurosurgery, and psychiatry.
[7] E. Perry,et al. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease , 1982, Neuroscience Letters.
[8] H. Soininen,et al. Neurotransmitter changes in alzheimer's disease: Implications to diagnostics and therapy , 1990, Journal of neuroscience research.
[9] D L Price,et al. Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.
[10] R. DeTeresa,et al. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease , 1988, Neurology.
[11] E. Masliah,et al. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. , 1991, The American journal of pathology.
[12] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[13] M. Mintun,et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] Y. Agid,et al. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia , 1982, Brain Research.
[15] D. Kuhl,et al. Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. , 1993, Nuclear medicine and biology.
[16] S. Kish,et al. [3H]Vesamicol binding in human brain cholinergic deficiency disorders , 1990, Neuroscience Letters.
[17] J. S. Benton,et al. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients , 1982, Journal of the Neurological Sciences.
[18] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[19] E. Perry,et al. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease , 1992, Neuroscience Letters.
[20] C. Altar,et al. Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183). , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[21] C D Marsden,et al. Altered Muscarinic and Nicotinic Receptor Densities in Cortical and Subcortical Brain Regions in Parkinson's Disease , 1993, Journal of neurochemistry.
[22] G Blomqvist,et al. Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[23] I. Nakano,et al. Parhnson’s Disease: Neuron Loss in the Nucleus Basah Without Concomitant Alzheimer’s Disease , 2004 .
[24] Yves Agid,et al. A subcortico-cortical cholinergic system is affected in Parkinson's disease , 1983, Brain Research.
[25] S. M. Sumi,et al. Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups , 1983, Annals of neurology.
[26] J. Coyle,et al. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.
[27] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[28] D. Sparks,et al. Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease , 1993, Annals of neurology.
[29] J. Mazziotta,et al. TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE , 1981 .
[30] M. V. Van Dort,et al. A radiotracer for mapping cholinergic neurons of the brain. , 1990, Journal of medicinal chemistry.
[31] G. Blessed,et al. NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA , 1977, The Lancet.
[32] S. Gauthier,et al. Differential Alteration of Various Cholinergic Markers in Cortical and Subcortical Regions of Human Brain in Alzheimer's Disease , 1988, Journal of neurochemistry.
[33] P. Eikelenboom,et al. Complement C4 phenotypes in dementia of the Alzheimer type. , 1988, Human heredity.
[34] R. S. J. Frackowiak,et al. REGIONAL CEREBRAL OXYGEN SUPPLY AND UTILIZATION IN DEMENTIAA CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN-15 AND POSITRON TOMOGRAPHY A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN - 15 AND POSITRON TOMOHRAPHY , 1981 .
[35] D E Kuhl,et al. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method , 1984, Annals of neurology.
[36] M. Decker. The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system , 1987, Brain Research Reviews.
[37] T. Powell,et al. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase , 1983, Brain Research.
[38] T Jones,et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. , 1981, Brain : a journal of neurology.
[39] A. Smith,et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease , 1994, The Lancet.
[40] G. Rogers,et al. Purification and Characterization of a Nonvesicular Vesamicol‐Binding Protein from Electric Organ and Demonstration of a Related Protein in Mammalian Brain , 1991, Journal of neurochemistry.
[41] D. Davies,et al. MYOCARDIAL DISORDERS IN THE ELDERLY. , 1963, Lancet.
[42] E. Perry,et al. Convergent cholinergic activities in aging and Alzheimer's disease , 1992, Neurobiology of Aging.
[43] C. Altar,et al. [3H]vesamicol binding in brain: Autoradiographic distribution, pharmacology, and effects of cholinergic lesions , 1988, Synapse.
[44] P. Richardson. Quantitation of Cholinergic Synaptosomes from Guinea Pig Brain , 1981, Journal of neurochemistry.
[45] T. Beach,et al. Cholinergic fiber loss occurs in the absence of synaptophysin depletion in Alzheimer's disease primary visual cortex , 1992, Neuroscience Letters.
[46] G. Rogers,et al. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). , 1989, Journal of medicinal chemistry.
[47] Bruno Dubois,et al. Cholinergic deficiency and frontal dysfunction in Parkinson's disease , 1990, Annals of neurology.
[48] D. Jewett,et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[49] Y. Agid,et al. Choline acetyltransferase activity and [ 3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions , 1990, Neuroscience.
[50] E. Perry,et al. Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases , 1983, Journal of the Neurological Sciences.
[51] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[52] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[53] G. Rogers,et al. Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants. , 1993, Molecular pharmacology.
[54] M. Roth,et al. Cortical neuronal counts in normal elderly controls and demented patients , 1983, Neurobiology of Aging.
[55] K Herholz,et al. Three-dimensional alignment of functional and morphological tomograms. , 1990, Journal of computer assisted tomography.
[56] L. Iversen,et al. Neurochemical characteristics of early and late onset types of Alzheimer's disease. , 1984, British medical journal.
[57] E. Perry. The cholinergic hypothesis--ten years on. , 1986, British medical bulletin.
[58] R. Koeppe,et al. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[59] J C Mazziotta,et al. Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.
[60] E. Perry,et al. Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease , 1993, Alzheimer disease and associated disorders.
[61] K. Davis,et al. Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.
[62] H. Fukuyama,et al. Coronal reconstruction images of glucose metabolism in Alzheimer's disease , 1991, Journal of the Neurological Sciences.
[63] Gwenn S. Smith,et al. EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS , 1989, The Lancet.
[64] R. Bartus,et al. The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.
[65] D E Kuhl,et al. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[66] J. Coyle,et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.
[67] P. Davies,et al. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.
[68] D M Bowen,et al. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.